Cell Therapeutics, Inc. (CTIC) - Earnings & Price History

CTIC: Cell Therapeutics, Inc. - 3.05, $98.98M, 0.00 (0.00%)

Sector: Healthcare - Industry: Biotechnology

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also developing Pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase III clinical trials for the treatment of myelofibrosis. In addition, it is developing Tosedostat, an oral once-daily aminopeptidase inhibitor that is in Phase II clinical trials for the treatment of acute myeloid leukemia; and Opaxio, a chemotherapeutic agent, which is in Phase III clinical trials for the treatment of va

Past CTIC reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-02AMC-0.64.454.494.534.334.590.89%-1.77%-0.89%129.14K
2017-02-17AMC-0.65
2017-02-16AMC-0.654.734.744.74.664.79-0.84%0.64%-0.21%66.77K
2017-02-15AMC-0.654.744.814.74.664.77-2.29%0.85%-1.46%86.36K
2017-02-14AMC-0.654.814.94.744.74.85-3.27%1.48%-1.84%180.75K
2016-11-04AMC-0.07
2016-11-03AMC-0.070.37220.370.3690.3640.3799-0.27%▲0.87%0.59%190.52K
2016-08-04AMC-0.10.35560.3710.3670.35230.3699-1.08%-3.11%-4.15%811.38K
2016-05-06AMC-0.04
2016-05-05AMC-0.040.44860.4510.4620.44390.46742.44%-2.90%-0.53%647.20K
2016-05-04AMC-0.040.4510.4440.470.450.485.86%-4.04%1.58%477.73K
2015-11-05AMC-0.121.331.371.351.31.35-1.46%▲-1.48%-2.92%1.35M
2015-10-28AMC-0.091.381.431.431.381.43-3.50%-3.50%533.31K
2015-10-27AMC-0.091.431.411.451.411.462.84%▲-1.38%1.42%2.01M
2015-08-06AMC-0.11.771.791.81.761.830.56%-1.67%-1.12%1.21M
2015-05-06AMC-0.141.761.741.781.721.82.30%-1.12%1.15%1.37M
2015-03-12AMC-0.181.972.62.41.932.4-7.69%-17.92%-24.23%26.27M
2014-10-29AMCCti Biopharma0.032.392.432.332.32.4-4.12%▲2.58%-1.65%1.12M
2014-08-04AMCCti Biopharma-0.12-0.192.422.512.372.352.46-5.58%2.11%-3.59%1.50M
2014-04-29AMCCell Therapeut-0.22.953.073.052.883.06-0.65%-3.28%-3.91%4.07M
2014-03-04AMCCell Therapeut-0.150.083.913.813.853.813.951.05%1.56%2.62%7.10M
2013-10-30AMCCell Therapeut-0.17-0.21.761.791.81.731.810.56%▲-2.22%-1.68%2.58M
2013-07-31AMCCell Therapeut-0.171.091.131.121.071.12-0.88%-2.68%-3.54%896.70K
2013-05-02AMC-0.441.131.171.151.131.17-1.71%-1.74%-3.42%634.20K
2013-02-28AMC-0.21.251.3451.281.191.2995-4.83%-2.34%-7.06%3.04M
2012-11-01BMOCell Therapeut-0.46-0.371.531.51.551.51.553.33%▲-1.29%2.00%899.60K
2012-10-31AMC-0.411.531.51.531.51.552.00%▲2.00%899.30K
2012-08-01BMOQ2 2012 Cell Therape-0.280.490.520.520.490.52-5.77%-5.77%240.30K
2012-04-25Cell Therapeut-0.1-0.091.131.161.151.121.17-0.86%-1.74%-2.59%209.20K
2012-04-20BMOQ1 2012 Cell Therape-0.5-0.451.171.161.211.161.214.31%-3.31%0.86%250.50K
2012-03-07BMOQ4 2011 Cell Therape-0.4-0.451.281.251.31.261.314.00%-1.54%2.40%383.60K
2011-10-25BMOQ3 2011 Cell Therape-0.45-0.81.251.241.31.251.34.84%▲-3.85%0.81%361.40K
2011-07-28BMOQ2 2011 Cell Therape-0.6-0.71.331.31.361.31.394.62%-2.21%2.31%198.80K
2011-04-27Q1 2011 Cell Therape-0.6-1.80.350.380.370.350.37-2.63%-5.41%-7.89%533.30K
2011-02-16BMOQ4 2010 Cell Therape-0.6-1.20.340.340.340.330.34146.10K
2010-10-28Q3 2010 Cell Therape-1.8-0.60.380.370.380.380.382.70%▲2.70%127.20K
2010-08-05Q2 2010 Cell Therape-0.6-2.40.410.410.40.40.41-2.44%2.50%33.50K
2010-04-28Q1 2010 Cell Therape-1.5-2.10.630.590.590.590.636.78%6.78%135.20K
2010-02-11Q4 2009 Cell Therape-0.9-1.50.720.770.750.710.77-2.60%-4.00%-6.49%555.40K
2009-11-05Q3 2009 Cell Therape-2.70.991.020.990.981.01-2.94%▲-2.94%159.20K
2009-08-17Cell Therapeut-0.051.571.571.541.531.61-1.91%1.95%670.90K
2009-08-06Q2 2009 Cell Therape-1.5-1.81.531.551.511.51.53-2.58%1.32%-1.29%395.20K
2009-05-07BMOQ1 2009 Cell Therape-9.45-1.51.071.271.30.981.482.36%-17.69%-15.75%2.88M
2009-03-16BMOQ4 2008 Cell Therape-48.9-15.60.110.080.090.080.1212.50%22.22%37.50%389.70K
2008-11-07Q3 2008 Cell Therape-99-84.90.330.320.340.30.346.25%▲-2.94%3.13%3.60K
2008-08-18BMOQ2 2008 Cell Therape-90-1560.330.330.330.310.331.70K
2008-05-08BMOQ1 2008 Cell Therape-127-2310.710.720.690.690.71-4.17%2.90%-1.39%4.10K
2008-03-13BMOQ4 2007 Cell Therape-157-2220.630.650.630.590.71-3.08%-3.08%2.50K
2007-11-08BMOQ3 2007 Cell Therape-189-1952.913.063.122.783.171.96%▲-6.73%-4.90%700
2007-08-08BMOQ2 2007 Cell Therape-190-1953.553.563.623.513.681.69%-1.93%-0.28%300
2007-05-02BMOQ1 2007 Cell Therape-156-2285.575.55.575.535.631.27%1.27%600
2007-03-15Q4 2006 Cell Therape-224-3001.591.651.581.551.61-4.24%0.63%-3.64%300
2006-11-07Q3 2006 Cell Therape-276-3001.521.51.531.51.542.00%▲-0.65%1.33%800
2006-08-08BMOQ2 2006 Cell Therape-294-2401.291.241.271.271.342.42%1.57%4.03%400
2006-05-04BMOQ1 2006 Cell Therape-354-7081.841.831.781.751.84-2.73%3.37%0.55%700
2006-03-09BMOQ4 2005 Cell Therape-196-3241.921.8921.892.035.82%-4.00%1.59%1.90K
2005-11-14BMOQ3 2005 Cell Therape-600-1562.342.372.382.342.390.42%▲-1.68%-1.27%300
2005-08-09Q2 2005 Cell Therape-642-6842.642.722.782.632.792.21%-5.04%-2.94%800
2005-05-02Q1 2005 Cell Therape-640-7443.443.723.63.43.68-3.23%-4.44%-7.53%1.10K
2005-02-28BMOQ4 2004 Cell Therape9.8410.1710.259.6510.250.79%-4.00%-3.24%2.40K
2004-11-09Q3 2004 Cell Therape7.26.736.76.637.37-0.45%▲7.46%6.98%1.60K
2004-07-27BMOQ2 2004 Cell Therape5.034.895.014.85.12.45%0.40%2.86%700
2004-05-06Q1 2004 Cell Therape7.588.238.117.38.11-1.46%-6.54%-7.90%800
2004-02-11BMOQ4 2003 Cell Therape9.699.569.429.159.75-1.46%2.87%1.36%300
2003-02-20BMOQ4 2002 Cell Therape5.885.455.525.516.071.28%6.52%7.89%800
2002-10-24BMOQ3 2002 Cell Therape4.915.215.284.895.281.34%▲-7.01%-5.76%400
2002-07-24BMOQ2 2002 Cell Therape3.243.443.182.883.36-7.56%1.89%-5.81%1.50K
2002-04-24BMOQ1 2002 Cell Therape13.8114.9814.7613.4514.94-1.47%-6.44%-7.81%1.70K
2002-02-20BMOQ4 2001 Cell Therape21.0920.5220.5220.0721.212.78%2.78%600
2001-10-22BMOQ3 2001 Cell Therape30.8829.327.3426.9931.35-6.69%▲12.95%5.39%2.30K
2001-07-26BMOQ2 2001 Cell Therape28.0428.2427.4927.2528.38-2.66%2.00%-0.71%1.30K
2001-04-26BMOQ1 2001 Cell Therape22.9224.224.122.7124.25-0.41%-4.90%-5.29%400
2001-02-15BMOQ4 2000 Cell Therape29.8833.8634.0529.7634.920.56%-12.25%-11.75%700
2000-10-19BMOQ3 2000 Cell Therape71.3468.169.8465.4973.212.56%▲2.15%4.76%300

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades